2013 HDCA Annual International Conference - "Human Development: Vulnerability, Inclusion and Wellbeing
9-12 September 2013, Managua Nicaragua
More information about the conference can be found at www.hdca2013.org
Conference registration now open click here to register
Haq Memorial Lectures
|The biennial Mahbub-ul-Haq Memorial Lecture is given by a leading academic or practitioner who has made important contributions to the field of Human Development, broadly understood. The lecture series commemorates the contribution of Mahbub-ul-Haq to this field.
|2011 Haq Memorial Lecture
|Speaker: Thomas Pogge (Commentator: Sakiko Fukuda-Parr)
||Date/location: September 7th 2011, The Hague, The Netherlands
|Title: "The Health Impact Fund as Justice-enhancing Institutional Innovation"
||Local Organiser: 3TU.Centre for Ethics & Technology
Abstract: One-third of all human lives end in early death from poverty-related causes. Many of these
premature deaths are avoidable through global health system reforms, including to the
existing patent regime. The latter provides incentives for the development and distribution of
new medicines; but it also leaves gaps, especially in poor regions.
The Health Impact Fund (HIF) is a mechanism intended to fill these gaps and to improve
access to new medicines worldwide. Funded mainly by governments, the HIF would give
pharmaceutical innovators the option to be rewarded according to the incremental health
impact of their product rather than through a patent-protected mark-up. The HIF would
stimulate the development of high-impact medicines (especially for currently neglected
diseases), would ensure that such products are available everywhere at no more than the
lowest feasible cost of manufacture and would encourage innovators to market such
medicines with the aim of reducing the global disease burden in the most cost-effective way.
The feasibility of this reform shows that the existing medical-patent regime (TRIPS as
supplemented by bilateral agreements) is severely unjust — and its imposition a human rights
violation on account of the avoidable mortality and morbidity it foreseeably produces.
In this talk I will (a) introduce the idea, (b) discuss its implementation, funding, and economic
viability, (c) explain its advantages for firms as well as the benefits for the health and welfare
of affluent and poor populations and (d) outline a moral justification of the HIF.
2011 HDCA Conference lecture slides